Tourmaline Bio's total assets for Q2 2025 were $269.30M, a decrease of -6.33% from the previous quarter. TRML total liabilities were $10.10M for the fiscal quarter, a 32.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.